ImmunoCellular Therapeutics Company
ImmunoCellular Therapeutics is focused on improving cancer treatment and diagnosis through the development of new immune-based products.
Technology:
Cell therapy
Industry:
Public
Headquarters:
Calabasas, California, United States
Founded Date:
2006-01-01
Employees Number:
1-10
Funding Status:
IPO
Investors Number:
2
Total Funding:
32470645
Estimated Revenue:
$10M to $50M
Last Funding Date:
2015-09-24
Last Funding Type:
Grant
Register and Claim Ownership